According to research report the ECMO Machine Market was valued at $531 million in 2021 and is expected to reach $673 million by 2026, growing at a compound annual growth rate of 4.9% during that period. ECMO machines provide prolonged cardiac and respiratory support to critically ill patients.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255167654

The growth of this market is driven primarily by the expanding geriatric population and increasing prevalence of chronic respiratory diseases and cardiovascular diseases globally. For instance, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. ECMO machines are increasingly being used in lung transplantation procedures as well, especially for patients with severe acute respiratory distress syndrome (ARDS).

Technological improvements have also boosted the adoption of ECMO machines. These systems allow for faster and more accurate diagnosis and treatment compared to older equipment. However, the high cost of ECMO therapies hinders wider adoption, especially in developing countries with constrained healthcare budgets and infrastructure. The expensive equipment, hospital stays, and need for specialized medical teams make ECMO therapy unaffordable for many patients. Declining insurance reimbursements pose an additional challenge.

Nonetheless, increasing ECMO machine usage has led to higher patient survival rates for critical cardiac and respiratory cases. This positive trend presents a key growth avenue for ECMO machine manufacturers and medical providers. Developing portable and easier-to-operate ECMO devices is another opportunity to expand the target market. Training programs to increase the number of qualified ECMO specialists could also aid growth.

The respiratory care segment accounted for the largest share of the global ECMO machine market in 2020. The rising prevalence of pulmonary diseases is driving demand for respiratory ECMO therapies. By modality, the arterio-venous segment dominated the market owing to its dynamic range and diagnostic value. Based on patient type, ECMO machine usage for adults contributed the greatest market share as the technology improves outcomes for older patients with heart and lung failure.

By component, ECMO machine controllers accounted for the largest share due to their affordability compared to other components like pumps and oxygenators. Meanwhile, portable ECMO machines are expected to dominate in the coming years due to their transportability to different hospital departments and mobility for critically ill patients.

Geographically, the Asia-Pacific region is poised to register the fastest growth rate in the global ECMO machine market through 2026. Key factors include the expanding elderly population, increasing disposable incomes, high disease burden, and supportive government policies in countries like Japan, China, and India.

Leading players in the global ECMO machine market include Getinge Group, Medtronic, Fresenius Medical Care, Microport, and Terumo Cardiovascular Systems Corporation. Market leaders are focused on new product development and partnerships to enhance their competitiveness. Recent key developments include regulatory approvals for new ECMO devices in the U.S. and China.

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=255167654

In summary, the rising prevalence of chronic cardiovascular and respiratory illnesses globally combined with technology improvements is propelling growth in the ECMO machine market. However, constraints around device costs, reimbursements, infrastructure and workforce availability curb faster adoption. Companies are investing in R&D and geographic expansion to tap this treatment market with strong growth potential in the coming years.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1–888–600–6441
[email protected]